Roundtable Discussion: Engineering Next-Generation Tregs to Advance Treg Therapeutic Development
- Investigating engineering Treg cells from CD4+ and iPSC precursors to understand the impact on efficacy
- Examining engineering strategies required to achieve durable Treg stability in vivo for long-term efficacy
- Engineering CAR-Tregs and Allogeneic Tregs for potential therapies of autoimmune and transplant disease
- Growth factor and durability support strategies for long term Treg persistence in patients